医源性直肠尿道瘘治疗和预后研究进展。
Advance in research of treatment and prognosis of iatrogenic rectourethral fistula.
机构信息
Department of Urology, Xiangya Hospital, Central South University, Changsha 410008.
Hunan Engineering Laboratory for Diagnosis and Treatment Technology of Urogenital Diseases, Changsha 410008, China.
出版信息
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Jul 28;46(7):753-758. doi: 10.11817/j.issn.1672-7347.2021.200617.
Recturethral fistula (RUF) is a kind of serious complication that mainly happened during the treatment of prostate cancer. It has become one of the most difficult diseases to treat in urology because of its special anatomical location, complicated condition, and the varied prognosis. At present, the main treatment methods for RUF are conservative treatment such as application of antibiotics and indwelling catheters, etc. and surgical treatment such as transperineal approach, transsphincter approach, transanal approach, transabdominal approach, etc. However, there is no explicit treatment protocol for RUF. What's more, the etiology of RUF has changed greatly in recent years. Summarizing the advantages and disadvantages of different RUF's treatment methods and their prognosis will be helpful for the decision of clinical treatment.
直肠瘘（RUF）是一种严重的并发症，主要发生在前列腺癌的治疗过程中。由于其特殊的解剖位置、复杂的病情和不同的预后，它已成为泌尿外科最难治疗的疾病之一。目前，RUF 的主要治疗方法包括应用抗生素和留置导管等保守治疗以及经会阴入路、经括约肌入路、经肛门入路、经腹入路等手术治疗。然而，目前还没有针对 RUF 的明确治疗方案。此外，RUF 的病因近年来发生了很大变化。总结不同 RUF 治疗方法的优缺点及其预后，有助于临床治疗决策。
Zotero 插件